Clinical Trial Update: MOv19-BBz CAR T Cells in FRa+ Cancers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating MOv19-BBz CAR T cells targeting FRα in metastatic or recurrent non-small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• MOv19-BBz CAR T Cells (MOv19-BBz CAR T cells)

Snippet

Sponsor: University of Pennsylvania | Conditions: Metastatic Non Small Cell Lung Cancer, Recurrent Lung Non-Small Cell Carcinoma | Phase 1 | Status: RECRUITING